Interactions between Immunosuppressive Therapy and Direct-Acting Antivirals in Kidney Transplant Recipient with Hepatitis C Infection
Hepatitis C virus (HCV) causes increased mortality and morbidity in kidney transplant patients. Interferon-based therapies are poorly tolerated and involve the risk of rejection. The new direct-acting antiviral drugs (DAAs) have revolutionized the treatment of HCV infection in transplant patients. T...
Saved in:
| Main Authors: | Paolo Carta, Federica Curci, Leonardo Caroti, Larti Aida, Lorenzo Di Maria, Lino Cirami |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Troika Publisher
2020-05-01
|
| Series: | Journal of Renal and Hepatic Disorders |
| Subjects: | |
| Online Access: | https://jrenhep.com/index.php/jrenhep/article/view/67 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Direct-Acting-Antivirals Anti-hepatitis C Virus in Renal Transplant Patients: Relevance of Pharmacologic Interaction
by: Maurizio Salvadori, et al.
Published: (2020-08-01) -
Conversion from Extended-Dose-Release Tacrolimus to Melt-Dose Tacrolimus in High Metabolizer Patients: Is the New Formulation of LPCT the Best Option for High Metabolizer Kidney Transplanted Patients?
by: Paolo Carta, et al.
Published: (2020-05-01) -
Biochemical characterization of a novel purified lectin extracted from Pleurotus ostreatus mushroom for its antiviral activity
by: Yousra A. El-Maradny, et al.
Published: (2025-07-01) -
Antivirals against HCV infection: the story thus far
by: Ahmad Adebayo Irekeola, et al.
Published: (2022-02-01) -
Efficacy of direct-acting antivirals in patients with hepatitis C virus-associated cryoglobulinemic vasculitis: Results of a long-term follow-up
by: S. V. Gavrisheva, et al.
Published: (2023-04-01)